Laxai Pharma, Ltd. (LAXAF) Research

Laxai Pharma, Ltd. is an American company that offers specialized contract research services. The firm provides extensive support throughout the entire pharmaceutical development process. Its areas of expertise include biostatistics, various data management methodologies (such as electronic, hybrid, and paper-based systems), CDISC advisory, medical documentation, clinical trial monitoring, regulatory compliance, pharmacovigilance, and associated training initiatives. The company, which was initially named Nexgen Biofuels Ltd., officially adopted the name Laxai Pharma, Ltd. in February 2010. Its headquarters are located in Tampa, Florida.

Market snapshot

Symbol
LAXAF
Price
$0.00
Day change
0.00%
Market cap
$475.3K
52-week range
1.0E-4-1.0E-4
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Alseres Pharmaceuticals, Inc. (ALSE)
  • Evolva Holding S.A. (ELVAY)
  • FluroTech Ltd. (FLURF)
  • Lotus Ventures Inc. (LTTSF)
  • Medical Services International Inc. (MSITF)
  • Phoenix Life Sciences International Limited (PLSI)
  • Rite Aid Corporation (RADCQ)
  • SugarBud Craft Growers Corp. (SBUDF)

Recent insider activity

  • UTA Capital LLC — J-Other (16800000 shares) on 2011-02-18
  • UTA Capital LLC — trade (7820000 shares) on 2010-07-01

Open Laxai Pharma, Ltd. (LAXAF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.